These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 23147664)

  • 61. Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular Carcinoma.
    Zhong BY; Ni CF; Chen L; Zhu HD; Teng GJ
    Radiology; 2017 Aug; 284(2):583-592. PubMed ID: 28263701
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Aggressive Treatment of Performance Status 1 and 2 HCC Patients Significantly Improves Survival - an Egyptian Retrospective Cohort Study of 524 Cases.
    Aziz AO; Omran D; Nabeel MM; Elbaz TM; Abdelmaksoud AH; Attar IE; Shousha HI
    Asian Pac J Cancer Prev; 2016; 17(5):2539-43. PubMed ID: 27268626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Zhu K; Huang J; Lai L; Huang W; Cai M; Zhou J; Guo Y; Chen J
    Radiology; 2018 Jul; 288(1):300-307. PubMed ID: 29688153
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A case of a patient with hepatocellular carcinoma who achieved long-term survival after repeated transcatheter arterial chemoembolization and sorafenib therapy].
    Mukai R; Wada H; Tomimaru Y; Hama N; Kawamoto K; Kobayashi S; Eguchi H; Umeshita K; Doki Y; Mori M; Nagano H
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1813-5. PubMed ID: 24393931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Managing localized unresectable hepatocellular carcinoma.
    Narang-Master J; Rizzolo D
    JAAPA; 2015 Jan; 28(1):27-34. PubMed ID: 25486501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
    de la Torre MA; Buades-Mateu J; de la Rosa PA; Lué A; Bustamante FJ; Serrano MT; Testillano M; Lorente S; Arenas JI; Gil C; Iñarrairaegui M; Sangro B
    Liver Int; 2016 Aug; 36(8):1206-12. PubMed ID: 26910784
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
    Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
    Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness analysis of transcatheter arterial chemoembolization with or without sorafenib for the treatment of unresectable hepatocellular carcinoma.
    Zhao RC; Zhou J; Wei YG; Liu F; Chen KF; Li Q; Li B
    Hepatobiliary Pancreat Dis Int; 2017 Oct; 16(5):493-498. PubMed ID: 28992881
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas.
    Liang HY; Lu LG; Hu BS; Li Y; Shao PJ
    Chin Med J (Engl); 2013 Nov; 126(22):4270-6. PubMed ID: 24238511
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of hepatocellular carcinoma with portal vein thrombosis.
    Quirk M; Kim YH; Saab S; Lee EW
    World J Gastroenterol; 2015 Mar; 21(12):3462-71. PubMed ID: 25834310
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multimodal approaches to the treatment of hepatocellular carcinoma.
    Cabibbo G; Latteri F; Antonucci M; Craxì A
    Nat Clin Pract Gastroenterol Hepatol; 2009 Mar; 6(3):159-69. PubMed ID: 19190599
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Real Life Treatment of Hepatocellular Carcinoma: Impact of Deviation from Guidelines for Recommended Therapy.
    Alkhatib A; Gomaa A; Allam N; Rewisha E; Waked I
    Asian Pac J Cancer Prev; 2015; 16(16):6929-34. PubMed ID: 26514470
    [TBL] [Abstract][Full Text] [Related]  

  • 73. TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.
    Geschwind JF; Kudo M; Marrero JA; Venook AP; Chen XP; Bronowicki JP; Dagher L; Furuse J; Ladrón de Guevara L; Papandreou C; Sanyal AJ; Takayama T; Ye SL; Yoon SK; Nakajima K; Lehr R; Heldner S; Lencioni R
    Radiology; 2016 May; 279(2):630-40. PubMed ID: 26744927
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adjuvant therapy for hepatocellular carcinoma after curative treatment.
    Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
    Dig Dis; 2014; 32(6):747-54. PubMed ID: 25376293
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Addition of local hepatic therapy to sorafenib in patients with advanced hepatocellular carcinoma (stage BCLC C).
    Schmidt L; op den Winkel M; Fischer K; Straub G; Rauch B; Paprottka PM; Göke B; Kolligs FT
    Digestion; 2014; 90(4):219-28. PubMed ID: 25502689
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
    Kan X; Jing Y; Wan QY; Pan JC; Han M; Yang Y; Zhu M; Wang Q; Liu KH
    Eur Rev Med Pharmacol Sci; 2015; 19(2):247-55. PubMed ID: 25683938
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Hepatocellular Carcinoma: New multimodal therapy concepts].
    Schultheiß M; Bettinger D; Fichtner-Feigl S; Thimme R
    Dtsch Med Wochenschr; 2018 Jun; 143(11):815-819. PubMed ID: 29807383
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Outcome of Sorafenib Therapy on Unresectable Hepatocellular Carcinoma: Experience of Conversion and Salvage Hepatectomy.
    Yoshimoto T; Imura S; Morine Y; Ikemoto T; Arakawa Y; Iwahashi S; Saito YU; Takasu C; Ishikawa D; Teraoku H; Bando Y; Shimada M
    Anticancer Res; 2018 Jan; 38(1):501-507. PubMed ID: 29277815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.
    Cui HZ; Dai GH; Shi Y; Chen L
    Hepatogastroenterology; 2013; 60(122):305-10. PubMed ID: 23574656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.